Literature DB >> 23663240

How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.

Lorraine M Elit1,2, Cathy Charles2, Amiram Gafni2,3, Jennifer Ranford4, Sara Tedford-Gold5, Irving Gold6.   

Abstract

BACKGROUND: Women with recurrent ovarian cancer depend on their physicians to provide them with information about their diagnosis and available treatment options if they wish to participate in the process of choosing the treatment. There is no information on how oncologists give information to women during the physician-patient encounter at the time the disease recurs.
OBJECTIVES: To explore from the oncologists' perspective (i) the extent to which oncologists provide their own patients who are experiencing their first recurrence of ovarian cancer with the same information about management options, and (ii) any explicit or implicit criteria they use to decide whether and how to tailor the information to individual patients.
METHODS: We adopted a qualitative, exploratory descriptive approach to begin to understand oncologists' perspectives on how they gave information to patients within the context of their clinical practice. Individual interviews were used to identify themes related to the study objectives.
RESULTS: Fifteen gynaecologic and five medical oncologists participated. Theme 1 describes the extent to which oncologists give information to their patients in the same way or in different ways. This section describes how the same oncologist may modify the depth of information transfer based on several factors. Theme 2 focuses on the factors that influence what information is given. For example, the amount and type of information given is based on the oncologist's on-going assessment of how the patient is assimilating the information shared during the medical encounter, the oncologists' perception of their relationship with the patient and the oncologist's assessment of what role they should take in decision making. Theme 3 involves the factors that influenced how information is given. For example, the information shared may vary based on the oncologist's perception of the patient's vitality, the patient's comprehension of the information, the patient's emotional well-being. In addition, the oncologist may make the information relevant for the patient by using analogies. Different types of information may be shared based on the oncologist's perception of patient- or family-initiated question. The information relay may be curtailed based on competing demands for the oncologist. DISCUSSION AND
CONCLUSIONS: Oncologists provide women with information on their disease status, their treatment options and the side effects of treatment. The oncologists use perceptions to determine what information and how to provide information. The question this paper raises is whether the oncologist's perceptions reflect the individual patient's information and decision-making needs.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  information giving; oncologist perspective; ovarian cancer; qualitative

Mesh:

Year:  2013        PMID: 23663240      PMCID: PMC5060889          DOI: 10.1111/hex.12079

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  14 in total

1.  The Roter interaction analysis system (RIAS): utility and flexibility for analysis of medical interactions.

Authors:  Debra Roter; Susan Larson
Journal:  Patient Educ Couns       Date:  2002-04

2.  Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter.

Authors:  Laurie Elit; Cathy Charles; Amiram Gafni; Jennifer Ranford; Sara Tedford Gold; Irving Gold
Journal:  Support Care Cancer       Date:  2011-12-14       Impact factor: 3.603

3.  Teaching communication and stress management skills to junior physicians dealing with cancer patients: a Belgian Interuniversity Curriculum.

Authors:  Isabelle Bragard; Darius Razavi; Serge Marchal; Isabelle Merckaert; Nicole Delvaux; Yves Libert; Christine Reynaert; Jacques Boniver; Jean Klastersky; Pierre Scalliet; Anne-Marie Etienne
Journal:  Support Care Cancer       Date:  2006-01-18       Impact factor: 3.603

4.  Do radiation oncologists tailor information to patients needs? And, if so, does it affect patients?

Authors:  Kirsten F L Douma; Caro C E Koning; Hanneke C J M de Haes; Linda C Zandbelt; Lukas J A Stalpers; Ellen M A Smets
Journal:  Acta Oncol       Date:  2012-03-13       Impact factor: 4.089

5.  Treatment decisions for breast carcinoma: patient preferences and physician perceptions.

Authors:  Eduardo Bruera; Jie S Willey; J Lynn Palmer; Marguerite Rosales
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

Review 6.  Cancer and patient-physician communication.

Authors:  Michael Diefenbach; Gina Turner; Kristen M Carpenter; Lisa Kennedy Sheldon; Karen M Mustian; Mary A Gerend; Christine Rini; Christian von Wagner; Ellen R Gritz; Amy McQueen; Heather M Prayor-Patterson; Suzanne M Miller
Journal:  J Health Commun       Date:  2009

7.  Treatment preferences in recurrent ovarian cancer.

Authors:  Kristine A Donovan; Paul G Greene; John L Shuster; Edward E Partridge; Diane C Tucker
Journal:  Gynecol Oncol       Date:  2002-08       Impact factor: 5.482

8.  Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.

Authors:  Elena B Elkin; Susie H M Kim; Ephraim S Casper; David W Kissane; Deborah Schrag
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

Review 9.  Health literacy, communication, and treatment decision-making in older cancer patients.

Authors:  Sunil Amalraj; Chelsea Starkweather; Christopher Nguyen; Arash Naeim
Journal:  Oncology (Williston Park)       Date:  2009-04-15       Impact factor: 2.990

Review 10.  Clinician-patient communication: a systematic review.

Authors:  Gary Rodin; Jean A Mackay; Camilla Zimmermann; Carole Mayer; Doris Howell; Mark Katz; Jonathan Sussman; Melissa Brouwers
Journal:  Support Care Cancer       Date:  2009-03-04       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.